Irgm1 Restrains CD8 + T Cell Cytokine Production and Apoptosis via Cell‐Extrinsic Regulation of Type I Interferon Signaling
European Journal of Immunology · 2026-04 · 56 (4)
DOI: 10.1002/eji.70113 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Immunology, online erschienen am 29.03.2026. Verfasst von Caitlyn T Molloy und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, North Carolina, USA. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Apoptosis, GTP-Binding Proteins, Interferon Type I. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Institute of Allergy and Infectious Diseases, NCI NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Immunity‐related GTPases (IRGs) are a family of proteins that maintain cellular homeostasis by promoting autophagy and mitophagy. Mutations in human IRGM and genetic deletion of mouse Irgm1 have been linked to increased severity of inflammatory bowel disease, cancer, sepsis, and various infections. While IRGM/Irgm1 are known cell‐intrinsic regulators of inflammation, their roles in T cell function remain poorly understood. We previously demonstrated that Irgm1 deficiency leads to increased production of proinflammatory mediators, including Granzyme B and interferon‐γ, and increased apoptosis in CD8 + T cells. Here, we show that Irgm1 deficiency also alters Granzyme B production and impairs virus‐specific CD8 + T cell responses during lymphocytic choriomeningitis virus (LCMV) infection. Using T cell‐specific Irgm1 knockout mice and adoptive transfer experiments, we unexpectedly found that Irgm1 regulates CD8 + T cell responses through a cell‐extrinsic mechanism. Transcriptomic and genetic analyses identified type I interferons (IFNs) as key mediators of this effect. These findings reveal a previously unrecognized, cell‐extrinsic role for Irgm1 in regulating CD8 + T cell survival and function by modulating the inflammatory environment. Our results suggest that IRGM/Irgm1 acts as a critical immune rheostat, restraining pathological inflammation and modulating T cell responses in infection and autoimmunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, North Carolina, USA.
- Department of Pediatrics, Division of Pediatric Endocrinology, University of North Carolina, Chapel Hill, North Carolina, USA.
- Department of Genetics, University of North Carolina, Chapel Hill, North Carolina, USA.
- Department of Medicine, Division of Geriatrics, and Center for the Study of Aging and Human Development, Duke University Medical Center, Durham, North Carolina, USA.
- Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina, USA.
- Department of Integrative Immunobiology, Duke University Medical Center, Durham, North Carolina, USA.
ORCID-Profile: Nancie J MacIver
Förderung
- National Institute of Allergy and Infectious Diseases
- NCI NIH HHS
- NIGMS NIH HHS
- NIDDK NIH HHS
- NIAID NIH HHS
Zitieren
APA
Molloy, C. T., Alwarawrah, Y., Cohen, J. A., Fee, B. E., Whitmire, J. K., Taylor, G. A., & MacIver, N. J. (2026). Irgm1 Restrains CD8 + T Cell Cytokine Production and Apoptosis via Cell‐Extrinsic Regulation of Type I Interferon Signaling. European Journal of Immunology, 56(4). https://doi.org/10.1002/eji.70113
Vancouver
Molloy CT, Alwarawrah Y, Cohen JA, Fee BE, Whitmire JK, Taylor GA, et al. Irgm1 Restrains CD8 + T Cell Cytokine Production and Apoptosis via Cell‐Extrinsic Regulation of Type I Interferon Signaling. European Journal of Immunology. 2026;56(4). doi:10.1002/eji.70113
BibTeX
@article{Molloy2026,
author = {Molloy, Caitlyn T and Alwarawrah, Yazan and Cohen, Jonathan A and Fee, Brian E and Whitmire, Jason K and Taylor, Gregory A and MacIver, Nancie J},
title = {Irgm1 Restrains CD8 + T Cell Cytokine Production and Apoptosis via Cell‐Extrinsic Regulation of Type I Interferon Signaling},
journal = {European Journal of Immunology},
year = {2026},
volume = {56},
number = {4},
doi = {10.1002/eji.70113}
}
EUVIMED